Cargando…

Clinical development innovation in rare diseases: lessons learned and best practices from the DevelopAKUre consortium

New opportunities have arisen for development of therapies for rare diseases with the increased focus and progress in the field. However, standardised framework integrating individual initiatives has not been formed. We present lessons learned and best practice from a collaborative success case in d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudebeck, Mattias, Scott, Ciarán, Rhodes, Nicholas P., van Kan, Christa, Olsson, Birgitta, Al-sbou, Mohammed, Hall, Anthony K., Sireau, Nicolas, Ranganath, Lakshminarayan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Position Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670024/ https://www.ncbi.nlm.nih.gov/pubmed/34906169 http://dx.doi.org/10.1186/s13023-021-02137-0

Ejemplares similares

Clinical development of nitisinone for alkaptonuria (developakure) - a rare disease clinical trials design
por: Psarelli, Eftychia Eirini, et al.
Publicado: (2013)

Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium
por: Javaid, Muhammad Kassim, et al.
Publicado: (2019)

A patient survey on the impact of alkaptonuria symptoms as perceived by the patients and their experiences of receiving diagnosis and care
por: Rudebeck, Mattias, et al.
Publicado: (2020)

Clinical management guidelines for Friedreich ataxia: best practice in rare diseases
por: Corben, Louise A., et al.
Publicado: (2022)

Optimising the diagnosis and referral of achondroplasia in Europe: European Achondroplasia Forum best practice recommendations
por: Cormier-Daire, Valerie, et al.
Publicado: (2022)

A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients
por: Lasch, Florian, et al.
Publicado: (2017)

Data silos are undermining drug development and failing rare disease patients
por: Denton, Nathan, et al.
Publicado: (2021)

Directions for new developments on statistical design and analysis of small population group trials
por: Hilgers, Ralf-Dieter, et al.
Publicado: (2016)

How to START? Four pillars to optimally begin your orphan drug development
por: Jonker, Anneliene Hechtelt, et al.
Publicado: (2023)

Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases
por: Douglas, Conor M. W., et al.
Publicado: (2022)

Sharing is caring: a call for a new era of rare disease research and development
por: Denton, Nathan, et al.
Publicado: (2022)

The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development
por: Heslop, Emma, et al.
Publicado: (2015)

Gaps in the evidence underpinning high-risk medical devices in Europe at market entry, and potential solutions
por: Hulstaert, Frank, et al.
Publicado: (2023)

The GoodHope Ehlers Danlos Syndrome Clinic: development and implementation of the first interdisciplinary program for multi-system issues in connective tissue disorders at the Toronto General Hospital
por: Mittal, Nimish, et al.
Publicado: (2021)

Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire survey
por: Sugawara, Yuka, et al.
Publicado: (2021)

Position Statements
Publicado: (2009)

Diabetes Care in the School and Day Care Setting
Publicado: (2009)

Third-Party Reimbursement for Diabetes Care, Self-Management Education, and Supplies
Publicado: (2009)

Diagnosis and Classification of Diabetes Mellitus
Publicado: (2009)

Diabetes Management in Correctional Institutions
Publicado: (2009)

Diabetes and Employment
Publicado: (2009)

Standards of Medical Care in Diabetes—2009
Publicado: (2009)

Regulation of Glucose Control in People with Type 2 Diabetes: A Review and Consensus
por: Woo, Jeong-Taek, et al.
Publicado: (2010)

Diabetes Management in Correctional Institutions
Publicado: (2011)

Position Statements
Publicado: (2011)

Diabetes and Employment
Publicado: (2011)

Standards of Medical Care in Diabetes—2011
Publicado: (2011)

Diagnosis and Classification of Diabetes Mellitus
Publicado: (2011)

Third-Party Reimbursement for Diabetes Care, Self-Management Education, and Supplies
Publicado: (2011)

Diabetes Care in the School and Day Care Setting
Publicado: (2011)

Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement
por: Colberg, Sheri R., et al.
Publicado: (2010)

Diabetes Management in Correctional Institutions
Publicado: (2010)

Diabetes and Employment
Publicado: (2010)

Standards of Medical Care in Diabetes—2010
Publicado: (2010)

Diagnosis and Classification of Diabetes Mellitus
Publicado: (2010)

Position Statements
Publicado: (2010)

Third-Party Reimbursement for Diabetes Care, Self-Management Education, and Supplies
Publicado: (2010)

Diabetes Care in the School and Day Care Setting
Publicado: (2010)

Summary of Revisions for the 2012 Clinical Practice Recommendations
Publicado: (2012)

Diabetes Management in Correctional Institutions
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bqa8ltlo7j1g30ecog81e3c02u